EXHIBIT 99.4
FOR IMMEDIATE RELEASE
Contact:
Michael Hoover
Chief Executive Officer
ProxyMed, Inc.
(954) 473-1001, ext. 300
PROXYMED, INC. APPOINTS MICHAEL K. HOOVER AS CHIEF EXECUTIVE OFFICER
AND CHAIRMAN OF THE BOARD
Ft Lauderdale, FL. August 15, 2000 - ProxyMed, Inc. (Nasdaq: PILL), a
leading provider of eHealth physician solutions and business-to-business
healthcare transaction services, today announced that effective today, Michael
K. Hoover has joined the Company as chief executive officer. Hoover, who is
former president of Healtheon Corporation, also will serve as the company's
chairman of the board. Harold Blue the interim CEO and Chairman will become Vice
Chairman.
"I am extremely pleased that Mike has accepted the position. We
searched for months and had many candidates, but no one had Mike's knowledge and
industry relationships in our two largest business segments, payers and medical
laboratories. Additionally, Mike gained tremendous internet and web technology
experience that is unsurpassed while he was president of Healtheon/WebMD. He is
uniquely qualified to move ProxyMed aggressively forward. Our board of directors
and myself could not be more pleased with the results of our search," said
Harold S. Blue, vice-chairman of ProxyMed, Inc.
Michael Hoover, age 44, served as president and director of Healtheon
Corporation (Nasdaq:HLTH) after Healtheon acquired ActaMed Corporation, an
e-health information systems and transaction company similar to ProxyMed, in May
1998. Mr. Hoover co-founded ActaMed in
<PAGE>
May 1992 and served as its president from its inception to May 1998, and as its
president and chief executive officer from December 1995 to May 1998. From 1989
to 1992, Mr. Hoover served as the executive director of Financial Services of
the MicroBit division of First Financial Management Corporation. Prior to that,
he founded FormMaker Software Corporation, a producer of electronic forms
automation systems, and served as its chief executive officer from 1982 to 1988.
"I am tremendously excited about this new and challenging eHealth
opportunity and look forward to working again with my friends throughout the
Healthcare industry," commented Hoover. "I had known ProxyMed for many years as
a respected competitor and since taking some time off, have been searching the
marketplace for the right opportunity. I concluded that ProxyMed, with its
existing connectivity, physician focus, and newly launched proxyMed.com portal,
stands out as a true contender for rapid growth in this burgeoning and dynamic
industry. Harold and the entire ProxyMed team have strategically positioned the
Company and built a solid foundation for me to contribute my expertise to
building greater shareholder value."
About ProxyMed, Inc.
ProxyMed, Inc. is among the nation's largest and most experienced eHealth
companies, supplying eSolutions to physicians and business-to-business
healthcare electronic commerce services to healthcare information systems
providers. The Company's desktop software and its proxyMed.com web site allow
physicians to exchange clinical and financial messages with insurance companies,
labs, pharmacies, suppliers, and patients in an efficient and secure manner -
simplifying financial, administrative, and clinical processes and resulting in
more cost-effective healthcare management and increased quality of patient care.
This press release contains forward-looking statements that reflect the
Company's current expectations regarding future events. While these statements
reflect the Company's best current judgment, they are subject to risks and
uncertainties. Actual results may differ significantly from projected results
due to a number of factors, including, but not limited to ProxyMed's ability to
abide by the assumptions, beliefs and opinions relating to ProxyMed's growth
strategy based upon ProxyMed's interpretation and analysis of healthcare
industry trends and management's ability to successfully develop, market, sell
and implement its e-commerce solutions, clinical and financial e-transaction
services and software applications to physicians, pharmacies, laboratories, and
payers. These factors and other risk factors are more fully discussed in the
Company's filings with the Securities and Exchange Commission. ProxyMed
expressly disclaims any intent or obligation to update any forward-looking
statements.
More information on ProxyMed is available on its home page at www.proxymed.com.
